Ryan Haggart
Overview
Explore the profile of Ryan Haggart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bates A, Ross M, Rosser B, Wheldon C, Polter E, Talley K, et al.
Stigma Health
. 2024 Nov;
9(4):506-517.
PMID: 39583622
The purpose of this study was to examine the experiences of discrimination during prostate cancer treatment and assess the association with health-related quality of life (HRQOL) in a cohort of...
2.
3.
Rosser B, Kohli N, Bates A, Talley K, Wright M, Polter E, et al.
J Cancer Surviv
. 2024 Sep;
PMID: 39266938
Purpose: Sexual minority prostate cancer patients have worse health-related quality of life outcomes than heterosexual patients. We conducted the first study to test whether sexual and urinary rehabilitation tailored for...
4.
Haggart R, Loftus C, Dewitt-Foy M, Henry V, Grove S, Pariser J, et al.
Urology
. 2024 Feb;
186:48-52.
PMID: 38387511
Objective: To evaluate urinary outcomes following cystoscopic external urinary sphincter onabotulinumtoxinA (BTX) injections in patients with cerebral palsy (CP). Adults with CP can suffer from bladder outlet obstruction and urinary...
5.
Wheldon C, Bates A, Polter E, Rosser B, Kapoor A, Talley K, et al.
J Sex Med
. 2023 Feb;
20(4):515-524.
PMID: 36796863
Background: Anodyspareunia may be an adverse outcome of prostate cancer (PCa) treatment for gay, bisexual, and other men who have sex with men (GBM). Aim: The aims of this study...
6.
Ross M, Rosser B, Polter E, Bates A, Wheldon C, Haggart R, et al.
Stigma Health
. 2023 Feb;
8(1):85-92.
PMID: 36779009
This study is the first to quantify experiences of discrimination in treatment undertaken by sexual and gender minority prostate cancer patients. Participants were 192 gay and bisexual and one transgender...
7.
Hoppe K, Smith M, Birstler J, Kim K, Sullivan-Vedder L, LaMantia J, et al.
JAMA Netw Open
. 2023 Feb;
6(2):e2255618.
PMID: 36735261
Importance: Uncontrolled hypertension (ie, a 24-hour ambulatory systolic blood pressure of ≥130 mm Hg and diastolic blood pressure of ≥80 mm Hg or clinic systolic blood pressure of ≥140 mm...
8.
Tatum A, Rosser B, Wheldon C, Torres M, Bates A, Haggart R, et al.
J Sex Res
. 2022 Oct;
60(5):752-761.
PMID: 36200951
Gay and bisexual men (GBM) with prostate cancer experience worse sexual and mental health outcomes following prostate cancer treatment than heterosexual men. Emerging evidence suggests that GBM may change their...
9.
Wheldon C, Polter E, Rosser B, Bates A, Haggart R, Wright M, et al.
Front Oncol
. 2022 May;
12:832508.
PMID: 35600390
Background: Equitable cancer survivorship care for gay and bisexual male (GBM) prostate cancer survivors should be responsive to their sexual health needs. Rates of sexually transmitted infections (STIs) are higher...
10.
Bates A, Rosser B, Polter E, Wheldon C, Talley K, Haggart R, et al.
Front Oncol
. 2022 May;
12:833197.
PMID: 35494011
Introduction: Prostate cancer treatment has established effects on the health-related quality of life (HRQOL) of patients. While racial/ethnic differences in HRQOL have been explored in heterosexual patients, this is the...